Cerebrolysin
70,00$
Description
Cerebrolysin is a proprietary injectable neuropeptide preparation derived from porcine brain tissue, containing a mixture of low-molecular-weight peptides and amino acids. It is extensively studied for its neuroprotective, neurotrophic, and cognitive-enhancing effects in preclinical and clinical models of stroke, traumatic brain injury (TBI), neurodegeneration, and cognitive impairment.
Epigenetix Labs provides Cerebrolysin as a research-grade, sterile solution for laboratory use only. This compound is not approved for human or veterinary use.
10 Research-Based Reasons to Study
- Neuronal survival and protection
- Promotes neuroplasticity and synaptic repair
- Reduces neuroinflammation
- Crosses the blood-brain barrier
- Cognitive and memory enhancement
- Broad application in brain injury and neurodegeneration models
- Multifactorial mechanism of action
- Neurotrophic signaling modulation
- Antioxidant defense in CNS
- Clinical and preclinical efficacy
Additional information
Additional information
| Weight | 0,008 kg |
|---|---|
| Dimensions | 1,5 × 1,5 × 4 cm |
| Research Applications | Stroke and traumatic brain injury models |
| Key Research Findings | Improves neurological outcomes after traumatic brain injury and stroke in animal models and human studies |
| Scientific background | Cerebrolysin contains neurotrophic factors, such as brain-derived neurotrophic factor (BDNF) analogs, nerve growth factor (NGF), ciliary neurotrophic factor (CNTF), and glial cell line-derived neurotrophic factor (GDNF), as well as a range of amino acids. |
| Purity & Manufacturing Standards | Epigenetix Labs Cerebrolysin is manufactured by enzymatic hydrolysis, purified by HPLC, and validated by MS. Each batch is produced in ISO 9001:2015-certified facilities. |
| Legal Disclaimer | This compound is provided for scientific laboratory use only. Not for human or veterinary use. Not evaluated by the FDA or regulatory authorities. |








Reviews
There are no reviews yet.